Browsing by Author "Chamizo, Cristina"

Sort by: Order: Results:

  • Dalmases Massegú, Alba, 1982-; González González, Irene; Menendez Romero, Silvia; Arpí Llucià, Oriol; Corominas Torres, Josep Maria; Servitja Tormo, Sonia; Tusquets Trias de Bes, Ignacio; Chamizo, Cristina; Rincón, Raúl; Espinosa Blay, Lluís; Bigas Salvans, Anna; Eroles, Pilar; Furriol, Jessica; Lluch, Ana; Rovira Guerín, Ana; Albanell Mestres, Joan; Rojo, Federico (Impact Journals, 2014)
    NF-кB has been linked to doxorubicin resistance in breast cancer patients. NF-кB nuclear translocation and DNA binding in doxorubicin treated-breast cancer cells have been extensively examined; however its functional ...
  • Zazo, Sandra; González-Alonso, Paula; Martín-Aparicio, Ester; Chamizo, Cristina; Cristóbal, Ion; Arpí Llucià, Oriol; Rovira Guerín, Ana; Albanell Mestres, Joan; Eroles, Pilar; Lluch, Ana; Madoz-Gúrpide, Juan; Rojo, Federico (e-Century Publishing, 2017)
    Trastuzumab became the therapy of choice for patients with HER2-positive breast cancer in 1998, and it has provided clinical benefit ever since. However, a significant percentage of patients show primary resistance to ...
  • Prieto-Potin, Iván; Carvajal, Nerea; Plaza-Sánchez, Jenifer; Manso, Rebeca; Aúz-Alexandre, Carmen Laura; Chamizo, Cristina; Zazo, Sandra; López-Sánchez, Almudena; Rodríguez-Pinilla, Socorro María; Camacho Díaz, Laura; Longarón Rozalen, Raquel; Bellosillo Paricio, Beatriz; Somoza, Rosa; Hernández-Losa, Javier; Fernández-Soria, Víctor Manuel; Ramos-Ruiz, Ricardo; Cristóbal, Ion; García-Foncillas, Jesús; Rojo, Federico (PeerJ Inc., 2020)
    Background: Next-generation sequencing (NGS) is a high-throughput technology that has become widely integrated in molecular diagnostics laboratories. Among the large diversity of NGS-based panels, the Trusight Tumor 26 ...

Search DSpace


My Account

In collaboration with Compliant to Partaking